Pages that link to "Q55400264"
Jump to navigation
Jump to search
The following pages link to Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial. (Q55400264):
Displaying 25 items.
- Systems biology approaches in the study of Chinese herbal formulae (Q60926052) (← links)
- Microbial Population Changes and Their Relationship with Human Health and Disease (Q64071480) (← links)
- Beneficial Effects of Bunge Water Extract on Inflammatory Cytokines Release and Gut Microbiota in High-Fat Diet and Streptozotocin-Induced Type 2 Diabetic Mice (Q64072112) (← links)
- Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity (Q64098043) (← links)
- Gut Microbiota, a Potential New Target for Chinese Herbal Medicines in Treating Diabetes Mellitus (Q64235692) (← links)
- Clostridium species as probiotics: potentials and challenges (Q89884842) (← links)
- Mechanisms of action of metformin with special reference to cardiovascular protection (Q90301380) (← links)
- Targeting Gut Microbiota for the Prevention and Management of Diabetes Mellitus by Dietary Natural Products (Q90311901) (← links)
- Effect of Metformin or Chinese Herbal Formula in Patients with Type 2 Diabetes Mellitus and Hyperlipidemia: A Reassessment (Q90451305) (← links)
- Bi-directional drug-microbiome interactions of anti-diabetics (Q90555954) (← links)
- Depletion of Blautia Species in the Microbiota of Obese Children Relates to Intestinal Inflammation and Metabolic Phenotype Worsening (Q90630010) (← links)
- Herbal Therapy for the Treatment of Acetaminophen-Associated Liver Injury: Recent Advances and Future Perspectives (Q90697492) (← links)
- Efficacy and safety assessment of traditional Chinese medicine for metabolic syndrome (Q90711160) (← links)
- The Intervention Effect of Traditional Chinese Medicine on the Intestinal Flora and Its Metabolites in Glycolipid Metabolic Disorders (Q91639794) (← links)
- Variability in the Response of Bacterial Community Assembly to Environmental Selection and Biotic Factors Depends on the Immigrated Bacteria, as Revealed by a Soil Microcosm Experiment (Q91655003) (← links)
- Association of suboptimal health status with intestinal microbiota in Chinese youths (Q91750350) (← links)
- Chinese herbal medicine Tangshen Formula treatment for type 2 diabetic kidney disease in the early stage: study protocol for a randomized controlled trial (Q92173171) (← links)
- Role of gut microbiota in type 2 diabetes pathophysiology (Q92416693) (← links)
- Relationship between alterations of urinary microbiota and cultured negative lower urinary tract symptoms in female type 2 diabetes patients (Q92787027) (← links)
- Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus (Q92797743) (← links)
- Roles of Chinese Medicine and Gut Microbiota in Chronic Constipation (Q93027737) (← links)
- Implication of gut microbiota in the association between infant antibiotic exposure and childhood obesity and adiposity accumulation (Q93163472) (← links)
- Dendrobium officinale Kimura et Migo and American ginseng mixture: A Chinese herbal formulation for gut microbiota modulation (Q96170645) (← links)
- Simiao Decoction Alleviates Gouty Arthritis by Modulating Proinflammatory Cytokines and the Gut Ecosystem (Q97517110) (← links)
- The effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A protocol for systematic review and meta-analysis (Q99590793) (← links)